Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.36 | 0.006 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |